<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75408</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Severe ovarian hyperstimulation syndrome after exogenous administration of human chorionic gonadotropin</dc:title>
<dc:description xml:lang="en">Severe ovarian hyperstimulation syndrome can occurafter administration of human chorionic gonadotropinused to induce ovulation in the context of in-vitrofertilization protocols. We report the case of a 27-yearoldwoman who had received gonadotropin treatment.In-vitro fertilization was successful but she developedabdominal pain, ascites, lower limb edema, dyspnea,bilateral pleural effusion, and adult respiratory distresssyndrome. The patient was admitted to the intensive careunit, where mechanical ventilation was started. Uterinedilatation and curettage was required to halt the process(AU)</dc:description>
<dc:creator>Ramos Aparici, R</dc:creator>
<dc:creator>Aznar Millán, O</dc:creator>
<dc:creator>Campos Pérez, J</dc:creator>
<dc:creator>Vila Sánchez, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de hiperestimulación ovárica grave esuna entidad clínica que puede ocurrir tras la administraciónde gonadotropina coriónica humana, utilizadapara inducir la ovulación en las pautas de estimulaciónovárica de la fecundación in vitro. Presentamos el casode una mujer de 27 años, que tras recibir tratamientocon gonadotropina y ser sometida a fertilización in vitroconsiguiendo gestación, presentó un cuadro clínico dedolor abdominal, ascitis, edemas en miembros inferiores,disnea, derrame pleural bilateral y síndrome de distrésrespiratorio del adulto. La paciente precisó ingreso en launidad de cuidados intensivos y ventilación mecánica,así como la realización de legrado uterino para frenar laprogresión del cuadro(AU)</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;56(9): 565-568, nov.2009. ilus, tab</dc:source>
<dc:identifier>ibc-75408</dc:identifier>
<dc:title xml:lang="es">Desarrollo de síndrome de hiperestimulación ovárica grave tras la administración exógena de gonadotropina coriónica humana</dc:title>
<dc:subject>^d29917^s22016</dc:subject>
<dc:subject>^d784^s22045</dc:subject>
<dc:subject>^d29917^s22012</dc:subject>
<dc:subject>^d29917^s22011</dc:subject>
<dc:subject>^d29917^s22032</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d32806^s22020</dc:subject>
<dc:subject>^d12541</dc:subject>
<dc:subject>^d24501^s22027</dc:subject>
<dc:subject>^d784^s22039</dc:subject>
<dc:subject>^d29917^s22009</dc:subject>
<dc:subject>^d6210^s22020</dc:subject>
<dc:type>article</dc:type>
<dc:date>200911</dc:date>
</metadata>
</record>
</ibecs-document>
